Literature DB >> 31641873

High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype.

Yoichi Kakuta1, Yasuhiro Izumiyama2, Daisuke Okamoto2, Takeru Nakano2, Ryo Ichikawa2, Takeo Naito2, Rintaro Moroi2, Masatake Kuroha2, Yoshitake Kanazawa2, Tomoya Kimura2, Hisashi Shiga2, Hisaaki Kudo3, Naoko Minegishi3, Yosuke Kawai4, Katsushi Tokunaga4, Masao Nagasaki5, Yoshitaka Kinouchi6, Yasuo Suzuki7, Atsushi Masasmune2.   

Abstract

BACKGROUND: The genetic variants of NUDT15 have been verified to induce adverse events (AEs) of thiopurines. Codon 139 variants are frequently observed in Asians, while multiple variants are seen in codon 18 which also cause AEs including the European ancestry. The purpose of this study is to establish a technique capable of the simple genotyping of NUDT15 codon 18 and to evaluate its efficacy.
METHODS: A high-resolution melt (HRM) technique is performed to simply determine genotypes. The accuracy of HRM analysis was evaluated with DNAs from 1245 Japanese patients with inflammatory bowel diseases. Subsequently, another group of 572 patients was analyzed to verify the method. The diplotypes and the frequency of their AEs were estimated on the basis of codon 18 and 139 genotypes.
RESULTS: The HRM analysis enabled the correct identification of the three main genotypes, ref/ref, ref/ins, and ref/V18I, in 1236 of 1241 cases. All rare genotypes including ref/del were identified as the impossible-to-determine group, the proper diagnosis rate was 99.6%. In the verification test using other samples, the diagnosis rate was 99.7%. By estimating diplotypes using both codon 18 and 139 genotypes, 2.74% and 2.13% of Japanese patients with Arg/Arg and Arg/Cys of codon 139 have a lower enzymatic activity of NUDT15 and a higher risk for adverse responses than those estimated by codon 139 genotypes alone.
CONCLUSIONS: Our study showed that HRM method enables simple genotyping of complicated codon 18 variants essential to haplotype estimation of the NUDT15.

Entities:  

Keywords:  Inflammatory bowel disease; NUDT15; Pharmacogenetics; Thiopurines

Mesh:

Substances:

Year:  2019        PMID: 31641873     DOI: 10.1007/s00535-019-01638-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  29 in total

1.  Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy.

Authors:  O Palmieri; A Latiano; F Bossa; M Vecchi; R D'Incà; D Guagnozzi; F Tonelli; S Cucchiara; M R Valvano; T Latiano; A Andriulli; V Annese
Journal:  Aliment Pharmacol Ther       Date:  2007-09-01       Impact factor: 8.171

2.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

3.  Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease.

Authors:  Hiromitsu Ban; Akira Andoh; Aiko Tanaka; Tomoyuki Tsujikawa; Masaya Sasaki; Yasuharu Saito; Yoshihide Fujiyama
Journal:  Intern Med       Date:  2008-10-01       Impact factor: 1.271

4.  Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.

Authors:  D P Jewell; S C Truelove
Journal:  Br Med J       Date:  1974-12-14

5.  NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.

Authors:  Ayumi Asada; Atsushi Nishida; Makoto Shioya; Hirotsugu Imaeda; Osamu Inatomi; Shigeki Bamba; Katsuyuki Kito; Mitsushige Sugimoto; Akira Andoh
Journal:  J Gastroenterol       Date:  2015-11-21       Impact factor: 7.527

6.  Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.

Authors:  Remo Panaccione; Subrata Ghosh; Stephen Middleton; Juan R Márquez; Boyd B Scott; Laurence Flint; Hubert J F van Hoogstraten; Annie C Chen; Hanzhe Zheng; Silvio Danese; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2014-02       Impact factor: 22.682

7.  Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.

Authors:  Noritaka Takatsu; Toshiyuki Matsui; Yuji Murakami; Hiroshi Ishihara; Takashi Hisabe; Takashi Nagahama; Shinichirou Maki; Takahiro Beppu; Yasuhiro Takaki; Fumihito Hirai; Kenshi Yao
Journal:  J Gastroenterol Hepatol       Date:  2009-07       Impact factor: 4.029

8.  A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs.

Authors:  Marzena Skrzypczak-Zielinska; Pawel Borun; Anna Bartkowiak-Kaczmarek; Oliwia Zakerska-Banaszak; Michal Walczak; Agnieszka Dobrowolska; Mateusz Kurzawski; Malgorzata Waszak; Daniel Lipinski; Andrzej Plawski; Ryszard Slomski
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

9.  Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.

Authors:  Gareth J Walker; James W Harrison; Graham A Heap; Michiel D Voskuil; Vibeke Andersen; Carl A Anderson; Ashwin N Ananthakrishnan; Jeffrey C Barrett; Laurent Beaugerie; Claire M Bewshea; Andy T Cole; Fraser R Cummings; Mark J Daly; Pierre Ellul; Richard N Fedorak; Eleonora A M Festen; Timothy H Florin; Daniel R Gaya; Jonas Halfvarson; Ailsa L Hart; Neel M Heerasing; Peter Hendy; Peter M Irving; Samuel E Jones; Jukka Koskela; James O Lindsay; John C Mansfield; Dermot McGovern; Miles Parkes; Richard C G Pollok; Subramaniam Ramakrishnan; David S Rampton; Manuel A Rivas; Richard K Russell; Michael Schultz; Shaji Sebastian; Philippe Seksik; Abhey Singh; Kenji So; Harry Sokol; Kavitha Subramaniam; Anthony Todd; Vito Annese; Rinse K Weersma; Ramnik Xavier; Rebecca Ward; Michael N Weedon; James R Goodhand; Nicholas A Kennedy; Tariq Ahmad
Journal:  JAMA       Date:  2019-02-26       Impact factor: 56.272

10.  The Tohoku Medical Megabank Project: Design and Mission.

Authors:  Shinichi Kuriyama; Nobuo Yaegashi; Fuji Nagami; Tomohiko Arai; Yoshio Kawaguchi; Noriko Osumi; Masaki Sakaida; Yoichi Suzuki; Keiko Nakayama; Hiroaki Hashizume; Gen Tamiya; Hiroshi Kawame; Kichiya Suzuki; Atsushi Hozawa; Naoki Nakaya; Masahiro Kikuya; Hirohito Metoki; Ichiro Tsuji; Nobuo Fuse; Hideyasu Kiyomoto; Junichi Sugawara; Akito Tsuboi; Shinichi Egawa; Kiyoshi Ito; Koichi Chida; Tadashi Ishii; Hiroaki Tomita; Yasuyuki Taki; Naoko Minegishi; Naoto Ishii; Jun Yasuda; Kazuhiko Igarashi; Ritsuko Shimizu; Masao Nagasaki; Seizo Koshiba; Kengo Kinoshita; Soichi Ogishima; Takako Takai-Igarashi; Teiji Tominaga; Osamu Tanabe; Noriaki Ohuchi; Toru Shimosegawa; Shigeo Kure; Hiroshi Tanaka; Sadayoshi Ito; Jiro Hitomi; Kozo Tanno; Motoyuki Nakamura; Kuniaki Ogasawara; Seiichiro Kobayashi; Kiyomi Sakata; Mamoru Satoh; Atsushi Shimizu; Makoto Sasaki; Ryujin Endo; Kenji Sobue; The Tohoku Medical Megabank Project Study Group; Masayuki Yamamoto
Journal:  J Epidemiol       Date:  2016-07-02       Impact factor: 3.211

View more
  5 in total

1.  A direct sequencing assay for pharmacogenetic testing of thiopurine-intolerant NUDT15 alleles in an Asian population.

Authors:  Kok-Siong Poon; Izz Irfan B Imran; Silvester Kheng-Han Chew; Patrice Tan; Karen Mei-Ling Tan
Journal:  BMC Res Notes       Date:  2022-04-25

Review 2.  Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases.

Authors:  Keiichi Tominaga; Takeshi Sugaya; Takanao Tanaka; Mimari Kanazawa; Makoto Iijima; Atsushi Irisawa
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 3.  Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease.

Authors:  Akira Andoh; Masahiro Kawahara; Takayuki Imai; Goichi Tatsumi; Osamu Inatomi; Yoichi Kakuta
Journal:  J Gastroenterol       Date:  2021-07-21       Impact factor: 7.527

4.  Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil.

Authors:  Juliana Carla Gomes Rodrigues; Tatiane Piedade de Souza; Lucas Favacho Pastana; André Maurício Ribeiro Dos Santos; Marianne Rodrigues Fernandes; Pablo Pinto; Alayde Vieira Wanderley; Sandro José de Souza; José Eduardo Kroll; Adenilson Leão Pereira; Leandro Magalhães; Laís Reis das Mercês; Amanda Ferreira Vidal; Tatiana Vinasco-Sandoval; Giovanna Chaves Cavalcante; João Farias Guerreiro; Paulo Pimentel de Assumpção; Ândrea Ribeiro-Dos-Santos; Sidney Santos; Ney Pereira Carneiro Dos Santos
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

5.  Rare Genotype of His/His in NUDT15 Codon 139 and Thiopurine-associated Adverse Events in a Case of Ulcerative Colitis.

Authors:  Kei Tomiyoshi; Hiroki Sato; Kentaro Tominaga; Yuzo Kawata; Daisuke Okamoto; Yoichi Kakuta; Junji Yokoyama; Shuji Terai
Journal:  Intern Med       Date:  2020-04-09       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.